Who
William Todd Horich
SVP, Commercial Operations
Company insider
Files Form 4 as: SVP, Commercial Operations, Supernus Pharmaceuticals.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $968K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Mar 2026
- Last trade
- 10 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $244K4,439 at $55.00 | filing |
| 10 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $244K4,439 at $55.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $240K4,438 at $54.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $240K4,438 at $54.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —2,625 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,125 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $67K1,216 at $54.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,625 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,125 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $94K1,718 at $54.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —1,125 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $29K521 at $54.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —2,625 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $67K1,216 at $54.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $94K1,718 at $54.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —1,125 at $0.00 | filing |
News
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026SUPN · manilatimes.net · 19 Oct 2026Supernus Pharmaceuticals (NASDAQ:SUPN) vs. Kiora Pharmaceuticals (NASDAQ:KPRX) Critical SurveySUPN · tickerreport.com · 11 Oct 2026Shineco (NASDAQ:SISI) vs. Supernus Pharmaceuticals (NASDAQ:SUPN) Financial AnalysisSUPN · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name William Todd Horich; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.